Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Insurers Remain Skeptical Of Public Plan As Sen. Schumer Rolls Out Proposal

Executive Summary

Representatives of the insurance industry and big business remained skeptical about the feasibility and fairness of a public insurance option competing with private plans during a Senate Finance Committee roundtable discussion May 5

You may also be interested in...



Pharma Cost-Saving Options Take Backseat In Senate Reform Roundtable

Proposals to pay for an expansion of health care coverage that would directly affect pharmaceuticals took a backseat to tax-related options during the Senate Finance Committee's May 12 roundtable discussion on financing health care reform

Pharma Cost-Saving Options Take Backseat In Senate Reform Roundtable

Proposals to pay for an expansion of health care coverage that would directly affect pharmaceuticals took a backseat to tax-related options during the Senate Finance Committee's May 12 roundtable discussion on financing health care reform

Pharma Share Of Health Reform Cost Savings To Come From Drug Access, Compliance, Personalized Medicine

As stakeholders pledge to reduce health system growth by $2 trillion over 10 years, Rep. Dingell urges support for public plan; Sen. Grassley wants more “concrete” proposals, CBO score.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS051044

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel